SFM
HZNP

Systematic Financial Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Systematic Financial Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,115
Closed -$340K – 505
2020
Q2 		$340K Sell
6,115
-7,050
-54% -$302K 0.02% 226
2020
Q1 		$390K Sell
13,165
-6,825
-34% -$231K 0.02% 228
2019
Q4 		$724K Hold
19,990
– – 0.03% 188
2019
Q3 		$544K Sell
19,990
-15,365
-43% -$397K 0.02% 341
2019
Q2 		$851K Sell
35,355
-22,300
-39% -$566K 0.03% 428
2019
Q1 		$1.52M Sell
57,655
-3,320
-5% -$78.7K 0.05% 265
2018
Q4 		$1.19M Sell
60,975
-9,205
-13% -$180K 0.04% 327
2018
Q3 		$1.37M Sell
70,180
-13,220
-16% -$251K 0.03% 415
2018
Q2 		$1.38M Sell
83,400
-17,160
-17% -$262K 0.03% 424
2018
Q1 		$1.43M Buy
+100,560
New +$1.49M 0.03% 358
2017
Q2 		– Sell
-96,375
Closed -$1.42M – 721
2017
Q1 		$1.42M Sell
96,375
-122,120
-56% -$1.98M 0.03% 545
2016
Q4 		$3.54M Buy
218,495
+106,810
+96% +$1.94M 0.06% 315
2016
Q3 		$2.02M Sell
111,685
-92,225
-45% -$1.8M 0.03% 329
2016
Q2 		$3.36M Sell
203,910
-215
-0.1% -$3.48K 0.05% 291
2016
Q1 		$3.38M Buy
204,125
+51,785
+34% +$906K 0.04% 292
2015
Q4 		$3.3M Buy
152,340
+76,335
+100% +$1.49M 0.04% 300
2015
Q3 		$1.51M Sell
76,005
-104,445
-58% -$3.3M 0.02% 566
2015
Q2 		$6.27M Sell
180,450
-368,305
-67% -$11.2M 0.05% 301
2015
Q1 		$14.3M Sell
548,755
-380,995
-41% -$6.98M 0.11% 202
2014
Q4 		$12M Buy
929,750
+46,900
+5% +$587K 0.09% 242
2014
Q3 		$10.8M Buy
882,850
+159,025
+22% +$1.85M 0.08% 255
2014
Q2 		$11.4M Buy
723,825
+226,175
+45% +$3.23M 0.08% 258
2014
Q1 		$7.52M Buy
497,650
+52,700
+12% +$595K 0.05% 304
2013
Q4 		$3.39M Buy
+444,950
New +$2.4M 0.02% 357

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Systematic Financial Management's HZNP Position: Q3 2020 in Review

Systematic Financial Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2020, closing a stake of 6,115 shares — an estimated $340K sold.

Systematic Financial Management first reported a position in HZNP in Q4 2013 and held it in 24 quarters. The position peaked at $14.3M in Q1 2015. 433 funds tracked by Wall St. Rank hold HZNP as of Q3 2020.

  • Systematic Financial Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2020 after selling out during the quarter.
  • Systematic Financial Management sold 6,115 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2020, an estimated $340K.
  • Systematic Financial Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 24 quarters.
  • Systematic Financial Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $14.3M in Q1 2015.
  • 433 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2020.

Based on Systematic Financial Management's 13F filing for Q3 2020, filed 12 Nov 2020.